您的位置: 首页 > 农业专利 > 详情页

METHODS OF TREATMENT WITH NATURAL KILLER CELLS MATCHED FOR KILLER IMMUNOGLOBULIN RECEPTOR TYPE
专利权人:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
发明人:
REZVANI, Katy,SHPALL, Elizabeth,LIU, Enli
申请号:
WO2016US36024
公开号:
WO2016197108(A1)
申请日:
2016.06.06
申请国别(地区):
世界知识产权组织国际局
年份:
2016
代理人:
摘要:
The present invention concerns methods of treating a disease such as leukemia in a subject by administering natural killer (NK) cells. In particular aspects, HLA-C1-licensed KIR2DL2/3 and KIR2DS2 NK cells are administered to a subject with an HLA-C genotype either homozygous or heterozygous for the C1 allele, or HLA-C2 licensed cells are administered to a subject with an HLA-C genotype homozygous for the C2 allele. In further aspects, the NK cells are genetically modified to express a chimeric antigen receptor and interleukin 15.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充